Clinical Study
Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin
Table 1
Characteristics of patients in the study groups and predelivery thrombosis risk factors.
| | Thromboprophylactic | Group A | Group B | | regimen | Bemiparin 3500 IU/5 days | Bemiparin 3500 IU/10 days |
| | Number of cases () | 311 | 335 | | Mean age ± SD | 31.37 ± 5.24 | 31.06 ± 5.62 | | Age ≥35 years (%) | 89 (28.61%) | 98 (29.25%) | | Parity () (%) | | | | 0 | 149 (47.9%) | 174 (51.9%) | | 1 | 90 (28.9%) | 101 (30.1%) | | 2 | 46 (14.8%) | 41 (12.2%) | | 3 | 13 (4.2%) | 13 (3.9%) | | ≥4 | 13 (4.2%) | 6 (1.8%) | | BMI () (%) | | | | BMI > 30 | 142 (45.8%) | 116 (34.62%) | | BMI > 35 | 36 (11.6%) | 22 (6.56%) | | Smoking () (%) | 51 (16.5%) | 40 (11.9%) | | >10 cigs./day | 16 (16%) | 9 (2.25%) | | Drug consumption () (%) | 1 (0.3%) | 1 (0.3%) | | Multiple pregnancy () (%) | 13 (4.2%) | 19 (5.6%) | | Hypertension () (%) | | | | Chronic hypertension | 6 (1.9%) | 0 | | PIH in previous pregnancy | 4 (1.3%) | 6 (1.8%) | | PIH in current pregnancy | 34 (10.9%) | 35 (10.4%) | | Diabetes () (%) | 15 (4.82%) | 26 (1.8%) | | Type I | 3 (1%) | 2 (0.6%) | | Gestational diabetes | 8 (2.6%) | 18 (5.4%) | | Carbohydrate intolerance | 4 (1.3%) | 6 (1.8%) | | Previous heart disease (%) | 0 | 1 (0.3%) | | Immobility () (%) | 0 | 1 (0.3%) |
|
|
BMI: body mass index, PIH: pregnancy-induced hypertension.
|
